Tomoko Maeda‐Chubachi

A phase 2, randomized dose-finding study of tapinarof (GSK2894512 cream) for the treatment of atopic dermatitis

Johnny Peppers, Amy S. Paller, Tomoko Maeda‐Chubachi et al. · Journal of the American Academy of Dermatology · 2018 · 157 citations

Dose-finding Study, Rheumatology, Atopic Dermatitis +5

Prevalence and incidence rates of cardiovascular, autoimmune, and other diseases in patients with psoriatic or psoriatic arthritis: a retrospective study using Clinical Practice Research Datalink

Emily Edson‐Heredia, Baojin Zhu, C. Lefèvre et al. · Journal of the European Academy of Dermatology and Venereology · 2014 · 94 citations

Phase 2, randomized dose-finding study of tapinarof (GSK2894512 cream) for the treatment of plaque psoriasis

K. Thomas Robbins, Robert Bissonnette, Tomoko Maeda‐Chubachi et al. · Journal of the American Academy of Dermatology · 2018 · 90 citations

Dose-finding Study, Pharmacology, Psoriatic Arthritis +6

Heterogeneity of Response to Biologic Treatment: Perspective for Psoriasis

Emily Edson‐Heredia, K.L. Sterling, Carlos Alatorre et al. · Journal of Investigative Dermatology · 2013 · 82 citations · Full text

Biologic Treatment, Medicine, Immunology +4

Itching is a significant problem and a mediator between disease severity and quality of life for patients with psoriasis: results from a randomized controlled trial

Baojin Zhu, Emily Edson‐Heredia, Jiaying Guo et al. · British Journal of Dermatology · 2014 · 62 citations